Clicky

Teva Pharmaceutical Industries(TEVA) News

Date Title
Nov 8 Teva to Present at the Jefferies London Healthcare Conference
Nov 8 Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
Nov 7 Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
Nov 7 TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase
Nov 7 Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...
Nov 6 Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript
Nov 6 Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge
Nov 6 Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say
Nov 6 Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report
Nov 6 Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS
Nov 5 What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
Nov 4 Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?
Nov 1 Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Nov 1 Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well ...
Nov 1 Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Nov 1 EC fines Teva $502m over multiple sclerosis treatment Copaxone practices
Oct 31 Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
Oct 31 EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Oct 31 Teva Statement on European Commission Decision; Company to Appeal
Oct 1 Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.